Skip to main content

Peer Review reports

From: Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences

Original Submission
19 Nov 2020 Submitted Original manuscript
28 Nov 2020 Reviewed Reviewer Report - D Gareth Evans
3 Dec 2020 Reviewed Reviewer Report - Pål Møller
15 Dec 2020 Author responded Author comments - Mary Velthuizen
Resubmission - Version 2
15 Dec 2020 Submitted Manuscript version 2
16 Dec 2020 Reviewed Reviewer Report - D Gareth Evans
16 Dec 2020 Reviewed Reviewer Report - Pål Møller
29 Dec 2020 Author responded Author comments - Mary Velthuizen
Resubmission - Version 3
29 Dec 2020 Submitted Manuscript version 3
5 Jan 2021 Reviewed Reviewer Report - Pål Møller
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
5 Jan 2021 Editorially accepted
19 Jan 2021 Article published 10.1186/s13053-021-00166-1

You can find further information about peer review here.

Back to article page